↓ Skip to main content

Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

Overview of attention for article published in Prostate Cancer and Prostatic Diseases, August 2005
Altmetric Badge

Mentioned by

patent
1 patent

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer
Published in
Prostate Cancer and Prostatic Diseases, August 2005
DOI 10.1038/sj.pcan.4500821
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 4 24%
Student > Master 3 18%
Student > Ph. D. Student 2 12%
Researcher 2 12%
Other 1 6%
Other 0 0%
Unknown 5 29%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 5 29%
Biochemistry, Genetics and Molecular Biology 2 12%
Computer Science 1 6%
Psychology 1 6%
Sports and Recreations 1 6%
Other 0 0%
Unknown 7 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2023.
All research outputs
#8,094,656
of 24,293,076 outputs
Outputs from Prostate Cancer and Prostatic Diseases
#703
of 1,174 outputs
Outputs of similar age
#21,497
of 60,250 outputs
Outputs of similar age from Prostate Cancer and Prostatic Diseases
#4
of 4 outputs
Altmetric has tracked 24,293,076 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,174 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 60,250 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.